Encompass More Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Buy
2,935
+52
+2% +$6.85K 0.05% 198
2026
Q1
$402K Sell
2,883
-23
-0.8% -$3.22K 0.07% 161
2025
Q4
$357K Sell
2,906
-8
-0.3% -$972 0.07% 182
2025
Q3
$323K Sell
2,914
-55
-2% -$6.25K 0.06% 167
2025
Q2
$329K Sell
2,969
-2,922
-50% -$311K 0.08% 155
2025
Q1
$660K Buy
5,891
+7
+0.1% +$722 0.2% 100
2024
Q4
$544K Buy
5,884
+1,066
+22% +$96K 0.18% 104
2024
Q3
$404K Buy
4,818
+524
+12% +$40K 0.15% 114
2024
Q2
$295K Buy
4,294
+427
+11% +$28.5K 0.21% 72
2024
Q1
$283K Buy
3,867
+1,166
+43% +$89.7K 0.23% 70
2023
Q4
$219K Buy
+2,701
New +$210K 0.25% 83

Other funds holding GILD

Encompass More Asset Management's GILD Position: Q2 2026 in Review

Encompass More Asset Management increased its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, buying an estimated $6.85K and bringing the position to 2,935 shares worth $371K. The position accounts for 0.05% of the portfolio, ranked #198.

Encompass More Asset Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $660K in Q1 2025. 341 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Encompass More Asset Management held 2,935 shares of Gilead Sciences worth $371K as of Q2 2026.
  • Encompass More Asset Management bought 52 Gilead Sciences shares in Q2 2026, an estimated $6.85K.
  • Gilead Sciences made up 0.05% of Encompass More Asset Management's portfolio in Q2 2026, its #198 holding.
  • Encompass More Asset Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Encompass More Asset Management's Gilead Sciences position peaked at $660K in Q1 2025.
  • 341 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Encompass More Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.